Galectins and Ovarian Cancer

被引:19
|
作者
Shimada, Chisa [1 ,2 ]
Xu, Rui [1 ,2 ]
Al-Alem, Linah [1 ,2 ]
Stasenko, Marina [3 ]
Spriggs, David R. [1 ,4 ]
Rueda, Bo R. [1 ,2 ,5 ]
机构
[1] Massachusetts Gen Hosp, Dept Obstet & Gynecol, Vincent Ctr Reprod Biol, Boston, MA 02114 USA
[2] Harvard Med Sch, Obstet Gynecol & Reprod Biol, Boston, MA 02115 USA
[3] Mem Sloan Kettering Canc Ctr, Gynecol Serv, 1275 York Ave, New York, NY 10065 USA
[4] Massachusetts Gen Hosp, Dept Hematol Med Oncol, Boston, MA 02114 USA
[5] Massachusetts Gen Hosp, Dept Obstet & Gynecol, Div Gynecol Oncol, Boston, MA 02114 USA
关键词
ovarian cancer; galectins; invasion; metastasis; chemoresistance; immune suppression; GALACTOSIDE-BINDING LECTIN; EPITHELIAL-MESENCHYMAL TRANSITION; TUMOR PROGRESSION; PROSTATE-CANCER; ELECTRIC ORGAN; CELL-MIGRATION; T-CELLS; APOPTOSIS; EXPRESSION; CARCINOMA;
D O I
10.3390/cancers12061421
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Ovarian cancer is known for its aggressive pathological features, including the capacity to undergo epithelial to mesenchymal transition, promoting angiogenesis, metastatic potential, chemoresistance, inhibiting apoptosis, immunosuppression and promoting stem-like features. Galectins, a family of glycan-binding proteins defined by a conserved carbohydrate recognition domain, can modulate many of these processes, enabling them to contribute to the pathology of ovarian cancer. Our goal herein was to review specific galectin members identified in the context of ovarian cancer, with emphasis on their association with clinical and pathological features, implied functions, diagnostic or prognostic potential and strategies being developed to disrupt their negative actions.
引用
收藏
页数:28
相关论文
共 50 条
  • [21] Critical appraisal of epigenetic regulation of galectins in cancer
    Gadwal, Ashita
    Modi, Anupama
    Khokhar, Manoj
    Vishnoi, Jeewan Ram
    Choudhary, Ramkaran
    Elhence, Poonam
    Banerjee, Mithu
    Purohit, Purvi
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2022, 27 (01) : 35 - 44
  • [22] Galectins in Esophageal Cancer: Current Knowledge and Future Perspectives
    Godefa, Tesfay M.
    Derks, Sarah
    Thijssen, Victor L. J. L.
    CANCERS, 2022, 14 (23)
  • [23] Glycans and galectins in prostate cancer biology, angiogenesis and metastasis
    Compagno, Daniel
    Gentilini, Lucas D.
    Jaworski, Felipe M.
    Gonzalez Perez, Ignacio
    Contrufo, Geraldine
    Laderach, Diego J.
    GLYCOBIOLOGY, 2014, 24 (10) : 899 - 906
  • [24] Galectins dysregulation: A way for cancer cells to invade and pervade
    Abdelfattah, Mahmoud M.
    Helwa, Reham
    ONCOLOGY RESEARCH, 2022, 30 (03) : 129 - 135
  • [25] Galectins in the tumor endothelium: opportunities for combined cancer therapy
    Thijssen, Victor L. J. L.
    Poirier, Francoise
    Baum, Linda G.
    Griffioen, Arjan W.
    BLOOD, 2007, 110 (08) : 2819 - 2827
  • [26] Galectins in Cancer and Translational Medicine: From Bench to Bedside
    Bartolazzi, Armando
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (10)
  • [27] Inhibition of galectins in cancer: Biological challenges for their clinical application
    Laderach, Diego Jose
    Compagno, Daniel
    FRONTIERS IN IMMUNOLOGY, 2023, 13
  • [28] Clinical significance of circulating galectins as colorectal cancer markers
    Watanabe, Makoto
    Takemasa, Ichiro
    Kaneko, Naoki
    Yokoyama, Yuhki
    Matsuo, El-Ichi
    Iwasa, Susumu
    Mori, Masaki
    Matsuura, Nariaki
    Monden, Morito
    Nishimura, Osamu
    ONCOLOGY REPORTS, 2011, 25 (05) : 1217 - 1226
  • [29] Angiostatic Cancer Therapy by Targeting Galectins in the Tumor Vasculature
    Schulkens, Iris A.
    Griffioen, Arjan W.
    Thijssen, Victor L.
    GALECTINS AND DISEASE IMPLICATIONS FOR TARGETED THERAPEUTICS, 2012, 1115 : 233 - 247
  • [30] Galectins
    Banfer, Sebastian
    Jacob, Ralf
    CURRENT BIOLOGY, 2022, 32 (09) : R406 - +